AbbVie Inc.
AbbVie Inc. 4AB.DU Peers
See (4AB.DU) competitors and their performances in Stock Market.
Stock Comparison
4AB.DU vs NOVC.DE Comparison
4AB.DU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4AB.DU stands at 292.94B. In comparison, NOVC.DE has a market cap of 406.69B. Regarding current trading prices, 4AB.DU is priced at $165.60, while NOVC.DE trades at $91.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4AB.DU currently has a P/E ratio of N/A, whereas NOVC.DE's P/E ratio is 22.91. In terms of profitability, 4AB.DU's ROE is +0.71%, compared to NOVC.DE's ROE of +0.86%. Regarding short-term risk, 4AB.DU is less volatile compared to NOVC.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4AB.DU.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NOVC.DE | $91.40 | -1.98% | 406.69B | 22.91 | $3.99 | N/A |
| 4AB.DU | $165.60 | +0.12% | 292.94B | N/A | N/A | +3.25% |
| W8A.DE | $9.94 | +0.89% | 8.59B | -1.68 | -$5.90 | +8.49% |
| RDC.DE | $124.90 | +1.13% | 2.54B | -55.02 | -$2.27 | N/A |
| SAE.DE | $88.30 | N/A | 1.61B | -26.60 | -$3.32 | N/A |
| NP5.DE | $8.62 | -4.22% | 172.06M | 10.14 | $0.85 | N/A |
| 2LYA.F | $2.12 | -1.17% | 171.59M | -42.40 | -$0.05 | N/A |
| 5EA.DE | $19.20 | N/A | N/A | N/A | N/A | N/A |